Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.73 |
| ▸ | LPL | P06858 | 12/20 | 0.73 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28718456 | 1.00 | LIPG (0.73) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL24449199 | 0.92 | LIPG (0.61) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL30216211 | 0.91 | LIPG (0.67) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL21065673 | 0.89 | LIPG (0.70) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL30462985 | 0.89 | LIPG (0.70) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL26048046 | 0.87 | LIPG (0.61) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL18270355 | 0.87 | LIPG (0.89) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL18270358 | 0.87 | LIPG (0.89) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL15282754 | 0.87 | LIPG (0.57) | LIPGLPLP4HBPDGFRBKDR | |
| SCHEMBL29918539 | 0.86 | LIPG (0.75) | LIPGLPLP4HBPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250374827-A1 | Triazine Compounds Substituted with Bulky Groups | NOVALED GMBH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-20250318430-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | NOVALED GMBH (DE) | 2025-10-09 | — | — | US | disclosed |
| US-12433156-B2 | Triazine compounds substituted with bulky groups | NOVALED GMBH (DE) | 2025-09-30 | — | — | US | disclosed |
| US-12382827-B2 | Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same | NOVALED GMBH (DE) | 2025-08-05 | — | — | US | disclosed |
| EP-3990450-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2024-11-06 | — | — | EP | disclosed |
| US-20240365661-A1 | Organic Light Emitting Diode and A Compound for Use Therein | NOVALED GMBH (DE) | 2024-10-31 | — | — | US | disclosed |
| WO-2023110330-A1 | COMPOUNDS FOR USE IN SEMICONDUCTIONG MATERIALS SUITABLE FOR ELECTRONIC DEVICES | NOVALED GMBH (DE) | 2023-06-22 | — | — | WO | disclosed |
| EP-4198026-A1 | COMPOUNDS FOR USE IN SEMICONDUCTIONG MATERIALS SUITABLE FOR ELECTRONIC DEVICES | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-4199133-A1 | ORGANIC LIGHT EMITTING DIODE, DISPLAY DEVICE COMPRISING THE SAME, AND COMPOUND | Novaled GmbH (DE) | 2023-06-21 | — | — | EP | disclosed |
| EP-3757100-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-20220165958-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | NOVALED GMBH (DE) | 2022-05-26 | — | — | US | disclosed |
| EP-3757100-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | Novaled GmbH (DE) | 2020-12-30 | — | — | EP | disclosed |
| WO-2020260406-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2020-12-30 | — | — | WO | disclosed |
| EP-3742513-A1 | ORGANIC LIGHT EMITTING DIODE | Novaled GmbH (DE) | 2020-11-25 | — | — | EP | disclosed |
| US-20200361916-A1 | Triazine Compounds substituted with Bulky Groups | SAMSUNG SDI CO. LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| US-20200361916-A1 | Triazine Compounds substituted with Bulky Groups | SAMSUNG SDI CO. LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| EP-3502106-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-3502106-B1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | NOVALED GMBH (DE) | 2020-09-02 | — | — | EP | disclosed |
| EP-3502106-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | Novaled GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
| EP-3502106-A1 | TRIAZINE COMPOUNDS SUBSTITUTED WITH BULKY GROUPS | Novaled GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433156-B2 | Triazine compounds substituted with bulky groups | CCNA1, CCNT1, CCNB1 | LIPG 3950/4885LPL 4023/4885P4HB 1727/4885 |
| US-20250374827-A1 | Triazine Compounds Substituted with Bulky Groups | CCNA1, CCNT1, CCNL2 | LIPG 4066/4885LPL 4297/4885P4HB 2831/4885 |
| US-20220165958-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | OCIAD1, AOX1, OCIAD2 | LIPG 609/4885LPL 222/4885P4HB 1533/4885 |
| US-20200361916-A1 | Triazine Compounds substituted with Bulky Groups | POU5F1, POU2F1, IKZF2 | LIPG 4760/4885LPL 4750/4885P4HB 2369/4885 |
| US-12382827-B2 | Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same | OCIAD1, AOX1, OCIAD2 | LIPG 609/4885LPL 222/4885P4HB 1533/4885 |
| US-20250318430-A1 | Compound and an Organic Semiconducting Layer, an Organic Electronic Device, a Display Device and a Lighting Device Comprising the Same | AOX1, OCIAD1, OCIAD2 | LIPG 630/4885LPL 239/4885P4HB 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.